ArticleCritical care medicine2025
Risk Analytics Clinical Decision Support Decreases Duration of Vasoactive Infusions Following Pediatric Cardiac Surgery: A Multicenter Before and After Clinical Trial.
Article in Critical care medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Case for the Pediatric Cardiologist-Informaticist.Pediatric cardiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectivesOur primary objective was to quantify the effect of a clinical decision support system (CDSS) informed by inadequate delivery of oxygen index (ID o2 ), an algorithm that estimates the probability of inadequate oxygen delivery on inotropes and vasoactive infusions (IVAI) postoperatively.
designMulticenter before-and-after study conducted between June 01, 2020, and December 31, 2022.
settingThree pediatric cardiac ICUs (CICUs) at tertiary academic children's hospitals. PATIENTS: Infants older than 36 weeks estimated gestational age and 2 kg following cardiac surgery with cardiopulmonary bypass, treated with IVAI greater than or equal to 6 hours.
interventionsClinicians committed to consider data from a CDSS informed by 6 hours rolling ID o2 average in their plan to wean IVAI postoperatively. Within the system, documentation of decisions incorporating these data prompted patient inclusion in the intervention arm. MEASUREMENTS AND MAIN
resultsThe primary outcome measure was IVAI duration. Secondary outcomes were CICU length of stay (LOS), rate of cardiac arrest (CA), and rate of IVAI weaning failure. Negative binomial and logistic regression models were used to assess differences between intervention and control groups. Age, sex, Society of Thoracic Surgeons-European association for Cardio-Thoracic Surgery (STAT) category, site, admit time, single-ventricle diagnosis, Vasoactive-Inotropic Score, and trial group were tested as input covariates. Three hundred forty-three and 432 patients were enrolled in the intervention and control groups, respectively. The intervention group included a higher proportion of STAT 4 patients and a lower proportion of STAT 1 patients (81 vs. 62; p < 0.01 and 43 vs. 108; p < 0.01, respectively). A risk-adjusted negative binomial regression model showed 29% shorter vasoactive infusion duration in the intervention group (95% CI, 14-42%; p < 0.01). There were no significant trends observed in CICU LOS, or occurrence rate of CA or weaning failure.
conclusionsA CDSS informed by ID o2 significantly decreased vasoactive infusions duration. There was no discernible change in ICU LOS, CA rate, or weaning failure rate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.